Research Site

Izumi-shi 594-0073

2 studies enrolling now · 5 studies all time

What they study most

Carcinoma, Non-Small Cell Lung, Chronic Obstructive Pulmonary Disease (COPD), Non-Small-Cell Lung Carcinoma NSCLC, Solid Tumor

Studies at this site

• A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer — Recruiting now
• A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease — Recruiting now
• Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC) — Running, not enrolling
• Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations — Completed
• Durvalumab Long-Term Safety and Efficacy Study — Completed